Cargando…

Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model

Translational researchers and clinicians recommend the use of large animal models in preclinical stroke research. This represents an important part of a strategy aiming to prevent past translational failures in future therapeutic developments. Thirty-five Merino rams were subjected to sham surgery (...

Descripción completa

Detalles Bibliográficos
Autores principales: Boltze, Johannes, Nitzsche, Björn, Geiger, Kathrin D., Schoon, Heinz-Adolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574567/
https://www.ncbi.nlm.nih.gov/pubmed/23440305
http://dx.doi.org/10.1007/s12975-011-0101-5
_version_ 1782259604838678528
author Boltze, Johannes
Nitzsche, Björn
Geiger, Kathrin D.
Schoon, Heinz-Adolf
author_facet Boltze, Johannes
Nitzsche, Björn
Geiger, Kathrin D.
Schoon, Heinz-Adolf
author_sort Boltze, Johannes
collection PubMed
description Translational researchers and clinicians recommend the use of large animal models in preclinical stroke research. This represents an important part of a strategy aiming to prevent past translational failures in future therapeutic developments. Thirty-five Merino rams were subjected to sham surgery (n = 3), one-branch middle cerebral artery occlusion (MCAO, n = 8) or total MCAO (n = 24). Twelve animals from the latter group received intravenous administration of 4 × 10(6) autologous mononuclear bone marrow cells (BM MNC) per kilogram 24 h after total MCAO. Animals were sacrificed at day 49 post MCAO. Histological investigations were performed to reveal (1) the impact of different MCAO modalities on a cellular level and (2) the influence of BM MNC therapy following stroke. Clear differences between one-branch and total MCAO were observed histologically with results being comparable to those seen in human patients. BM MNC treatment reduced final lesion extension, lymphocytic infiltration and axonal degeneration after MCAO. The sheep model may represent a feasible tool for translational stroke research as pathohistological findings mimic the situation in humans. Histological evidence was found for beneficial impact of autologous BM MNC therapy. Further studies are needed to assess the neurofunctional impact of the approach in the gyrencephalic brain.
format Online
Article
Text
id pubmed-3574567
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35745672013-02-21 Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model Boltze, Johannes Nitzsche, Björn Geiger, Kathrin D. Schoon, Heinz-Adolf Transl Stroke Res Cell-based Therapies for Stroke Translational researchers and clinicians recommend the use of large animal models in preclinical stroke research. This represents an important part of a strategy aiming to prevent past translational failures in future therapeutic developments. Thirty-five Merino rams were subjected to sham surgery (n = 3), one-branch middle cerebral artery occlusion (MCAO, n = 8) or total MCAO (n = 24). Twelve animals from the latter group received intravenous administration of 4 × 10(6) autologous mononuclear bone marrow cells (BM MNC) per kilogram 24 h after total MCAO. Animals were sacrificed at day 49 post MCAO. Histological investigations were performed to reveal (1) the impact of different MCAO modalities on a cellular level and (2) the influence of BM MNC therapy following stroke. Clear differences between one-branch and total MCAO were observed histologically with results being comparable to those seen in human patients. BM MNC treatment reduced final lesion extension, lymphocytic infiltration and axonal degeneration after MCAO. The sheep model may represent a feasible tool for translational stroke research as pathohistological findings mimic the situation in humans. Histological evidence was found for beneficial impact of autologous BM MNC therapy. Further studies are needed to assess the neurofunctional impact of the approach in the gyrencephalic brain. Springer-Verlag 2011-08-23 2011-09 /pmc/articles/PMC3574567/ /pubmed/23440305 http://dx.doi.org/10.1007/s12975-011-0101-5 Text en © Springer Science+Business Media, LLC 2011
spellingShingle Cell-based Therapies for Stroke
Boltze, Johannes
Nitzsche, Björn
Geiger, Kathrin D.
Schoon, Heinz-Adolf
Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title_full Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title_fullStr Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title_full_unstemmed Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title_short Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model
title_sort histopathological investigation of different mcao modalities and impact of autologous bone marrow mononuclear cell administration in an ovine stroke model
topic Cell-based Therapies for Stroke
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574567/
https://www.ncbi.nlm.nih.gov/pubmed/23440305
http://dx.doi.org/10.1007/s12975-011-0101-5
work_keys_str_mv AT boltzejohannes histopathologicalinvestigationofdifferentmcaomodalitiesandimpactofautologousbonemarrowmononuclearcelladministrationinanovinestrokemodel
AT nitzschebjorn histopathologicalinvestigationofdifferentmcaomodalitiesandimpactofautologousbonemarrowmononuclearcelladministrationinanovinestrokemodel
AT geigerkathrind histopathologicalinvestigationofdifferentmcaomodalitiesandimpactofautologousbonemarrowmononuclearcelladministrationinanovinestrokemodel
AT schoonheinzadolf histopathologicalinvestigationofdifferentmcaomodalitiesandimpactofautologousbonemarrowmononuclearcelladministrationinanovinestrokemodel